Government Secures $114.5M In False Claims Act Recoveries From Cancer Genetic Testing Kickback Scheme
Posted 07/22/25
By the Constantine Cannon Whistleblower Team
Last Thursday (July 17), the Department of Justice (DOJ) announced the final False Claims Act recovery in a cancer genetic testing kickback scheme involving the Medicaid programs of Colorado, Georgia, and South Carolina.1 Kevin Murdock, former owner and CEO of the now-defunct testing lab Premier Medical, agreed to a consent judgment of roughly $27.5...
Hill Associates to Pay $14.75 Million to Settle False Claims Act Charges of Cybersecurity and Other IT Contract Failures
Posted 07/16/25
By the Constantine Cannon Whistleblower Team
On Monday (July 14), Maryland-based federal contractor Hill Associates agreed to pay at least $14.75 million to settle Department of Justice (DOJ) charges it violated the False Claims Act by violating several key provisions of its General Services Administration (GSA) contract for information technology (IT) services. Hill’s payout would have been higher but for the...
Health Wealth Will Pay $1.29M to Resolve Whistleblower-Initiated False Claims Act Lawsuit
Posted 07/2/25
By the Constantine Cannon Whistleblower Team
Georgia-based Health Wealth Safe, Inc. (Health Wealth) and its owner, Dr. Subodh Agrawal, have agreed to pay $1.29 million to settle allegations that they knowingly caused the submission of false claims to Medicare.
Whistleblower Lawsuit Filed by Former Employee
This lawsuit was brought under the whistleblower or qui tam provisions of the False Claims Act (FCA) by a...
Catholic Health Pays Over $3M to Resolve False Claims Act Allegations
Posted 05/28/25
By the Constantine Cannon Whistleblower Team
On May 16, U.S. Attorney Michael DiGiacomo announced that Catholic Health System, Inc. (CHS) agreed to pay $3,293,122.66 to settle False Claims Act allegations that it knowingly submitted or caused the submission of false claims to the Medicare program by engaging in improper financial relationships with physicians in violation of the Stark Law1.
Assertio to Pay $3.6M in False Claims Act Settlement over Fentanyl Marketing Practices
Posted 05/21/25
By the Constantine Cannon Whistleblower Team
On May 9, the government announced that Assertio Therapeutics Inc., (formerly Depomed Inc.) (“Assertio”), agreed to pay $3.6 million to resolve False Claims Act allegations stemming from its marketing of Lazanda, its transmucosal immediate-release fentanyl (TIRF) drug. This case was initiated by whistleblowers.1
Lazanda is a nasal spray solely approved by the...
CoreLife Eatery Admits to Pandemic Relief Fraud in Whistleblower Initiated Case, Will Pay $7.8M
Posted 05/20/25
By the Constantine Cannon Whistleblower Team
On May 5, the government announced that the restaurant chain CoreLife Eatery, LLC admitted to misrepresenting its eligibility for pandemic relief funds. The business, which operates locations in Illinois, Kentucky, Ohio, Pennsylvania, and New York, agreed to pay $7,809,373 to resolve allegations that it violated the False Claims Act by falsely certifying its eligibility...
Genexe and Its Entities Will Pay $6M to Settle False Claims Act Allegations, Case Brought by Four Whistleblowers
Posted 05/13/25
By the Constantine Cannon Whistleblower Team
On April 23, the government announced that Genexe LLC, its marketing company Immerge, Inc., and two of its owners, Jason Green and Jason Gross, will pay $6 million to settle allegations that they violated the False Claims Act and Anti-Kickback Statute.
The now-defunct Genexe once billed itself as a “one-stop-shop” for genetic and pharmacogenetic profiling,...
Trump Administration Signals Strong Commitment to Stopping Cybersecurity Fraud
Posted 05/6/25
By the Constantine Cannon Whistleblower Team
On May 1, the Department of Justice (DOJ) settled its latest cybersecurity enforcement action, showing the Government’s continued commitment to using the False Claims Act to go after cybersecurity fraud. Under the settlement, RTX subsidiary Raytheon Company and Nightwing Group agreed to pay $8.4 million to settle charges of violating key cybersecurity requirements in...
Gilead Pays $202M to Settle False Claims Act Kickback Charges
Posted 05/5/25
By the Constantine Cannon Whistleblower Team
On April 29, the Department of Justice (DOJ) announced that California-based pharmaceutical giant Gilead Sciences agreed to pay $202 million to settle charges of violating the False Claims Act and Anti-Kickback Statute. Specifically, the government alleged Gilead provided financial inducements to physicians to speak at or attend sham medical conferences to induce them...
NJ Rehab Center Will Pay $19.75M to Resolve False Claims Act Allegations
Posted 05/2/25
On April 30, a New Jersey-based drug and alcohol rehabilitation facility, Summit BHC New Jersey, LLC, d/b/a Seabrook, agreed to pay $19.75 million to resolve allegations that it violated the False Claims Act by billing for services it was not authorized to provide. This case was initiated by a former Seabrook employee who filed suit under the whistleblower or qui tam provisions of the False Claims Act.
According to...